866-997-4948(US-Canada Toll Free)

United States Radiopharmaceuticals Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 107 Pages

In this report, the United States Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Radiopharmaceuticals market competition by top manufacturers/players, with Radiopharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Radiopharmaceuticals for each application, including
Oncology
Cardiology
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Radiopharmaceuticals Market Report 2017
1 Radiopharmaceuticals Overview
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Classification of Radiopharmaceuticals by Product Category
1.2.1 United States Radiopharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Radiopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Radioisotopes
1.2.4 Therapeutic Radioisotopes
1.3 United States Radiopharmaceuticals Market by Application/End Users
1.3.1 United States Radiopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 United States Radiopharmaceuticals Market by Region
1.4.1 United States Radiopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.3 Southwest Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.5 New England Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.6 The South Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.7 The Midwest Radiopharmaceuticals Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Radiopharmaceuticals (2012-2022)
1.5.1 United States Radiopharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 United States Radiopharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Radiopharmaceuticals Market Competition by Players/Suppliers
2.1 United States Radiopharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Radiopharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Radiopharmaceuticals Average Price by Players/Suppliers (2012-2017)
2.4 United States Radiopharmaceuticals Market Competitive Situation and Trends
2.4.1 United States Radiopharmaceuticals Market Concentration Rate
2.4.2 United States Radiopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Radiopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Radiopharmaceuticals Sales and Market Share by Region (2012-2017)
3.2 United States Radiopharmaceuticals Revenue and Market Share by Region (2012-2017)
3.3 United States Radiopharmaceuticals Price by Region (2012-2017)

4 United States Radiopharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Radiopharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Radiopharmaceuticals Revenue and Market Share by Type (2012-2017)
4.3 United States Radiopharmaceuticals Price by Type (2012-2017)
4.4 United States Radiopharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Radiopharmaceuticals Sales (Volume) by Application (2012-2017)
5.1 United States Radiopharmaceuticals Sales and Market Share by Application (2012-2017)
5.2 United States Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Radiopharmaceuticals Players/Suppliers Profiles and Sales Data
6.1 Bracco Imaging
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Radiopharmaceuticals Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bayer
6.2.2 Radiopharmaceuticals Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Mallinckrodt
6.3.2 Radiopharmaceuticals Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Nordion
6.4.2 Radiopharmaceuticals Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Triad Isotopes
6.5.2 Radiopharmaceuticals Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Lantheus
6.6.2 Radiopharmaceuticals Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 IBA Group
6.7.2 Radiopharmaceuticals Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GE Healthcare
6.8.2 Radiopharmaceuticals Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 China Isotope & Radiation
6.9.2 Radiopharmaceuticals Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Jubilant Pharma
6.10.2 Radiopharmaceuticals Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Eli Lilly
6.12 Advanced Accelerator Applications
6.13 SIEMENS
6.14 Dongcheng
6.15 Navidea

7 Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radiopharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Radiopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Radiopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Radiopharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Radiopharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Radiopharmaceuticals Sales Volume Forecast by Type (2017-2022)
11.3 United States Radiopharmaceuticals Sales Volume Forecast by Application (2017-2022)
11.4 United States Radiopharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals
Figure United States Radiopharmaceuticals Market Size (K Doses) by Type (2012-2022)
Figure United States Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure United States Radiopharmaceuticals Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Radiopharmaceuticals by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Radiopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure The West Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals Sales Share by Players/Suppliers
Figure United States Radiopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals Revenue Share by Players/Suppliers
Table United States Market Radiopharmaceuticals Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Radiopharmaceuticals Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Radiopharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States Radiopharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Radiopharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Radiopharmaceuticals Product Category
Table United States Radiopharmaceuticals Sales (K Doses) by Region (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Region in 2016
Table United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Revenue Market Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Revenue Market Share by Region in 2016
Table United States Radiopharmaceuticals Price (USD/Dose) by Region (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) by Type (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Type in 2016
Table United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Type in 2016
Table United States Radiopharmaceuticals Price (USD/Dose) by Types (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth Rate by Type (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) by Application (2012-2017)
Table United States Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Application in 2016
Table United States Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bayer Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Bayer Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Bayer Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Nordion Basic Information List
Table Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Nordion Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Nordion Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Nordion Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Lantheus Basic Information List
Table Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Lantheus Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure IBA Group Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Jubilant Pharma Basic Information List
Table Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals
Figure Manufacturing Process Analysis of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals Major Players/Suppliers in 2016
Table Major Buyers of Radiopharmaceuticals
Table Distributors/Traders List
Figure United States Radiopharmaceuticals Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type in 2022
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application in 2022
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *